Rare diseases, trends and challenges for scientific advances: a snapshot of a decade of research in Brazil

Autores

Palavras-chave:

Rare Diseases, Database, Clinical Trial, Public Policy

Resumo

Brazil is home to around 13 million rare disease patients, which represents a significant challenge for biomedical research and public health. This descriptive and exploratory study analyzed research protocols on rare diseases submitted to Plataforma Brasil between 2013 and 2023, with the aim of identifying trends, challenges and opportunities for scientific progress in this area. The research evaluated variables such as the number of studies submitted and approved, sample characteristics, type of study, experimental design, research phase, participation in international networks, and epidemiological data (ICD). The results indicate a substantial increase in the number of protocols submitted over the period analyzed, with an average approval rate of 87.26%. Most of the studies were conducted in public institutions, highlighting the fundamental role of the public sector in rare disease research in Brazil. These findings suggest a growing investment and interest in research in this area, which could boost the development of new therapies and interventions, as well as supporting the formulation of more effective public policies to meet the needs of patients with rare diseases.

Downloads

Não há dados estatísticos.

Referências

BRASIL. Health ministry. Agência Nacional de Vigilância Sanitária. Brasília, DF, [2024]c. Available at: https://www.gov.br/anvisa/pt-br. Accessed on: 23 jul. 2024.

BRASIL. Health ministry. Brasília, DF, [2024]a. Available at: https://www.gov.br/saude/pt-br. Accessed on: 23 jul. 2024.

BRASIL. Health ministry. Composição: Atenção Especializada à Saúde: doenças raras. Brasília, DF, [2024]b. Available at: https://www.gov.br/saude/pt-br/composicao/saes/doencas-raras. Accessed on: 23 jul. 2024.

BRASIL. Health ministry. Conselho Nacional de Saúde. Comissão Nacional de Ética em Pesquisa. Brasília, DF, [2024]d. Available at: https://conselho.saude.gov.br/comissoes-cns/conep/. Accessed on: 23 jul. 2024.

BRASIL. Health ministry. Conselho Nacional de Saúde. Resolução nº 466, de 12 de dezembro de 2012. Brasília, DF, 2012. Available at: https://conselho.saude.gov.br/resolucoes/2012/Reso466.pdf. Accessed on: 23 jul. 2024.

BRASIL. Health ministry. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada e Temática. Coordenação Geral de Média e Alta Complexidade. Diretrizes para Atenção Integral às Pessoas com Doenças Raras no Sistema Único de Saúde – SUS: Portaria GM/MS nº 199 de 30/01/2014. Brasília, DF: Health ministry, 2014. 41 p.

BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Plataforma Brasil. Brasília, DF, 2023. Available at: https://conselho.saude.gov.br/plataforma-brasil-conep?view=default. Accessed on: 23 jul. 2024.

REDE NACIONAL DE DOENÇAS RARAS – RARAS. [S. l.], [2024]. Available at: https://raras.org.br/. Accessed on: 23 jul. 2024.

RODRIGUEZ-MONGUIO, R.; SPARGO, T.; SEOANE-VAZQUEZ, E. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs? Orphanet Journal of Rare Diseases, [s. l.], v. 12, n. 1, p.1-8, 2017. DOI: https://doi.org/10.1186/s13023-016-0551-7. Available at: https://www.researchgate.net/publication/312106852_Ethical_Imperatives_of_Timely_Access_to_Orphan_Drugs_Is_Possible_to_Reconcile_Economic_Incentives_and_Patients'_Health_Needs. Accessed on: 23 jul. 2024.

SANTORO, M.; COI, A.; DI PAOLA, M. L.; BIANUCCI, A. M.; GAINOTTI, S.; MOLLO, E.; TARÚSCIO, D. de; VITTOZZI, L.; BIANCHI, F. Classificação e caracterização dos registros de doenças raras: uma mineração de dados Abordagem. Genômica em Saúde Pública, [s. l.], v. 18, p. 113-122, 2015. DOI: https://doi.org/10.1159/000369993.

THE R PROJECT FOR STATISTICAL COMPUTING. [S. l.], [2024]. Available at: https://www.r-project.org/. Accessed on: 23 jul. 2024.

Downloads

Publicado

2024-09-23

Edição

Seção

Articles